Daniel Spinks

1.2k total citations
22 papers, 747 citations indexed

About

Daniel Spinks is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Daniel Spinks has authored 22 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Organic Chemistry and 10 papers in Epidemiology. Recurrent topics in Daniel Spinks's work include Trypanosoma species research and implications (10 papers), Research on Leishmaniasis Studies (8 papers) and Synthesis and Biological Evaluation (6 papers). Daniel Spinks is often cited by papers focused on Trypanosoma species research and implications (10 papers), Research on Leishmaniasis Studies (8 papers) and Synthesis and Biological Evaluation (6 papers). Daniel Spinks collaborates with scholars based in United Kingdom, Norway and Switzerland. Daniel Spinks's co-authors include Alan H. Fairlamb, Ian H. Gilbert, Paul G. Wyatt, Julie A. Frearson, Stephen Thompson, Ruth Brenk, Sandra L. Oza, Leah S. Torrie, Susan Wyllie and Justin R. Harrison and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Molecular Microbiology.

In The Last Decade

Daniel Spinks

22 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Spinks United Kingdom 16 372 288 267 264 74 22 747
Iain T. Collie United Kingdom 11 264 0.7× 127 0.4× 187 0.7× 116 0.4× 97 1.3× 14 505
Clifford Bryant United States 13 385 1.0× 142 0.5× 130 0.5× 125 0.5× 77 1.0× 17 623
Joseline Ratnam United States 11 153 0.4× 129 0.4× 128 0.5× 110 0.4× 79 1.1× 11 462
Ramesh Gujjar United States 11 416 1.1× 198 0.7× 229 0.9× 175 0.7× 64 0.9× 12 928
Priyadarshini Jaishankar United States 15 522 1.4× 235 0.8× 177 0.7× 66 0.3× 58 0.8× 28 970
Leslie J. Street Switzerland 15 209 0.6× 44 0.2× 171 0.6× 162 0.6× 187 2.5× 23 593
Geoffrey S. Dow United States 15 232 0.6× 40 0.1× 237 0.9× 321 1.2× 34 0.5× 26 778
Gautam Patel United States 16 160 0.4× 107 0.4× 465 1.7× 120 0.5× 9 0.1× 23 733
Silvia Galiano Spain 15 162 0.4× 100 0.3× 511 1.9× 166 0.6× 28 0.4× 29 721
G.F. Ruda United Kingdom 15 513 1.4× 71 0.2× 131 0.5× 43 0.2× 113 1.5× 20 719

Countries citing papers authored by Daniel Spinks

Since Specialization
Citations

This map shows the geographic impact of Daniel Spinks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Spinks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Spinks more than expected).

Fields of papers citing papers by Daniel Spinks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Spinks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Spinks. The network helps show where Daniel Spinks may publish in the future.

Co-authorship network of co-authors of Daniel Spinks

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Spinks. A scholar is included among the top collaborators of Daniel Spinks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Spinks. Daniel Spinks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Michael G., Manu De Rycker, John Thomas, et al.. (2018). 2,4-Diamino-6-methylpyrimidines for the potential treatment of Chagas’ disease. Bioorganic & Medicinal Chemistry Letters. 28(18). 3025–3030. 4 indexed citations
2.
Hallyburton, Irene, Raffaella Grimaldi, Andrew Woodland, et al.. (2017). Screening a protein kinase inhibitor library against Plasmodium falciparum. Malaria Journal. 16(1). 446–446. 16 indexed citations
3.
Spinks, Daniel, Victoria Smith, Stephen Thompson, et al.. (2015). Development of Small‐Molecule Trypanosoma brucei N‐Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode. ChemMedChem. 10(11). 1821–1836. 18 indexed citations
4.
Spinks, Daniel, Leah S. Torrie, Stephen Thompson, et al.. (2011). Design, Synthesis and Biological Evaluation of Trypanosoma brucei Trypanothione Synthetase Inhibitors. ChemMedChem. 7(1). 95–106. 36 indexed citations
5.
Smith, Victoria, Laura A. T. Cleghorn, Andrew Woodland, et al.. (2011). Optimisation of the Anti‐Trypanosoma brucei Activity of the Opioid Agonist U50488. ChemMedChem. 6(10). 1832–1840. 6 indexed citations
6.
Brand, Stephen, Laura A. T. Cleghorn, Stuart P. McElroy, et al.. (2011). Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors. Journal of Medicinal Chemistry. 55(1). 140–152. 93 indexed citations
7.
Reid, Mark, Wilson Caulfield, Ola Epemolu, et al.. (2010). The discovery and SAR of indoline-3-carboxamides—A new series of 5-HT6 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(12). 3713–3716. 6 indexed citations
8.
Spinks, Daniel, Han B. Ong, Chidochangu P. Mpamhanga, et al.. (2010). Design, Synthesis and Biological Evaluation of Novel Inhibitors of Trypanosoma brucei Pteridine Reductase 1. ChemMedChem. 6(2). 302–308. 32 indexed citations
9.
Wyllie, Susan, Sandra L. Oza, Stephen Patterson, et al.. (2009). Dissecting the essentiality of the bifunctional trypanothione synthetase‐amidase in Trypanosoma brucei using chemical and genetic methods. Molecular Microbiology. 74(3). 529–540. 59 indexed citations
10.
Spinks, Daniel, Emma Shanks, Laura A. T. Cleghorn, et al.. (2009). Investigation of Trypanothione Reductase as a Drug Target in Trypanosoma brucei. ChemMedChem. 4(12). 2060–2069. 43 indexed citations
11.
Torrie, Leah S., Susan Wyllie, Daniel Spinks, et al.. (2009). Chemical Validation of Trypanothione Synthetase. Journal of Biological Chemistry. 284(52). 36137–36145. 62 indexed citations
12.
Mpamhanga, Chidochangu P., Daniel Spinks, L.B. Tulloch, et al.. (2009). One Scaffold, Three Binding Modes: Novel and Selective Pteridine Reductase 1 Inhibitors Derived from Fragment Hits Discovered by Virtual Screening. Journal of Medicinal Chemistry. 52(14). 4454–4465. 83 indexed citations
13.
Adams, David R., Jun Asano, Catherine Breslin, et al.. (2007). 2-Aryl-3,3,3-trifluoro-2-hydroxypropionic acids: A new class of protein tyrosine phosphatase 1B inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(23). 6579–6583. 26 indexed citations
14.
McPhee, Ian, et al.. (2005). Cyclic nucleotide signalling: a molecular approach to drug discovery for Alzheimer's disease. Biochemical Society Transactions. 33(6). 1330–1330. 63 indexed citations
15.
Spinks, Daniel, et al.. (2004). Serotonin Reuptake Inhibition: An Update on Current Research Strategies. 1(1). 347–359. 4 indexed citations
16.
17.
Spinks, Daniel, et al.. (2002). Serotonin Reuptake Inhibition: An Update on Current Research Strategies. Current Medicinal Chemistry. 9(8). 799–810. 70 indexed citations
18.
19.
Fletcher, Stephen R., Peter Blurton, R.B. Clarkson, et al.. (2001). 4-(Phenylsulfonyl)piperidines:  Novel, Selective, and Bioavailable 5-HT2AReceptor Antagonists. Journal of Medicinal Chemistry. 45(2). 492–503. 44 indexed citations
20.
Slater, Matthew James, Amanda Bird, Daniel Spinks, et al.. (1998). Biaryl acids: Novel non-nucleoside inhibitors of HIV reverse transcriptase types 1 and 2. Bioorganic & Medicinal Chemistry Letters. 8(19). 2623–2628. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iain T. Collie Breakdown of academic impact, for papers by Clifford Bryant Breakdown of academic impact, for papers by Joseline Ratnam Breakdown of academic impact, for papers by Ramesh Gujjar Breakdown of academic impact, for papers by Priyadarshini Jaishankar Breakdown of academic impact, for papers by Leslie J. Street Breakdown of academic impact, for papers by Geoffrey S. Dow Breakdown of academic impact, for papers by Gautam Patel Breakdown of academic impact, for papers by Silvia Galiano Breakdown of academic impact, for papers by G.F. Ruda
Rankless by CCL
2026